Bradykinin antagonists: new opportunities

被引：50
作者：
Bock, MG [1 ]
Longmore, J
机构：
[1] Merck Res Labs, W Point, PA 19486 USA
[2] Merck Sharp & Dohme Ltd, Res Labs, Neurosci Res Ctr, Harlow CM20 2QR, Essex, England
来源：
CURRENT OPINION IN CHEMICAL BIOLOGY | 2000年 / 4卷 / 04期
关键词：
D O I：
10.1016/S1367-5931(00)00107-1
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The pro-inflammatory, pain producing, and cardiovascular effects of bradykinin B-2 receptor activation are well characterized. Bradykinin B-1 receptors also produce inflammation and pain. Therefore, antagonists are expected to be anti-inflammatory/analgesic drugs. Other exploitable clinical opportunities may exist. The newly discovered non-peptide B-2 receptor antagonists and the equivalent B-1 receptor pharmacological agents, which are in the pipeline, are suitable preclinical tools to properly evaluate potential utilities.
引用
收藏
页码：401 / 406
页数：6
相关论文
共 37 条
  • [21] Small molecule antagonists of the bradykinin B1 receptor
    Horlick, RA
    Ohlmeyer, MH
    Stroke, IL
    Strohl, B
    Pan, GH
    Schilling, AE
    Paradkar, V
    Quintero, JG
    You, M
    Riviello, C
    Thorn, MB
    Damaj, B
    Fitzpatrick, VD
    Dolle, RE
    Webb, ML
    Baldwin, JJ
    Sigal, NH
    [J]. IMMUNOPHARMACOLOGY, 1999, 43 (2-3): : 169 - 177
  • [22] Kayakiri Hiroshi, 1999, Drugs of the Future, V24, P629, DOI 10.1358/dof.1999.024.06.545142
  • [23] LEE YJ, 2000, LIFE SCI, V307, P94
  • [24] Role of the bradykinin B2 receptor in the maturation of blood pressure phenotype, lesson from transgenic and knockout mice
    Madeddu, P
    Emanueli, C
    Gaspa, L
    Salis, B
    Milia, AF
    Chao, L
    Chao, J
    [J]. IMMUNOPHARMACOLOGY, 1999, 44 (1-2): : 9 - 13
  • [25] KININ B-1 RECEPTORS - A REVIEW
    MARCEAU, F
    [J]. IMMUNOPHARMACOLOGY, 1995, 30 (01): : 1 - 26
  • [26] Meini S, 1999, J PHARMACOL EXP THER, V289, P1250
  • [27] Acetylillustrol: A new compound from Mandevilla illustris (Vell.) Woodson (Apocynaceae)
    Niero, R
    Calixto, JB
    Filho, JDDS
    Yunes, RA
    Sant'ana, AEG
    [J]. NATURAL PRODUCT LETTERS, 1999, 13 (01): : 63 - 70
  • [28] Bradykinin B1 receptor expression and function on T lymphocytes in active multiple sclerosis
    Prat, A
    Weinrib, L
    Becher, B
    Poirier, J
    Duquette, P
    Couture, R
    Antel, JP
    [J]. NEUROLOGY, 1999, 53 (09) : 2087 - 2092
  • [29] In vitro and in vivo effects of the new nonpeptide bradykinin B2 receptor antagonist, LF 16-0335C, on guinea-pig and rat kinin receptors
    Pruneau, D
    Luccarini, JM
    Fouchet, C
    Defrêne, E
    Franck, RM
    Loillier, B
    Duclos, H
    Robert, C
    Cremers, B
    Bélichard, P
    Paquet, JL
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1999, 13 (01) : 75 - 83
  • [30] PRUNEAU D, 1998, 15 INT C KIN 1998 OC
1234